September 9, 2020

Study Finds Higher-Than-Expected Rate of CV Events in Adults With Influenza

Pharmacists might be surprised to learn that about 12% of influenza patients develop sudden, severe heart complications. The best protection is an annual vaccine, making it more important than ever that everyone is immunized over the next few months. Here is more information.


Blood Pressure Medication Use Doesn’t Increase Cancer Risk
in Patients

The debate has been going on for decades: Do blood pressure medications increase the risk for cancer? A presentation at the recent European Society of Cardiology meeting touts itself as the final answer, finding no evidence that any type of antihypertensive increases risk of any type of cancer, even with long-term use. Here are more details. 

COVID-19 Infection During Pregnancy Adversely Affects Mothers, Newborns

Many pharmacists have fielded questions from jittery women worried about how COVID-19 would affect their pregnancies and unborn children. A new meta-analysis and review suggests that their concerns are realistic. Find out how expectant mothers present differently with COVID-19 and how the infection appears to have more serious consequences for them and their newborns.


SGLT2 Inhibitors Are Beneficial Even for Patients With Severe Heart Failure

In a likely practice-changing study, researchers have demonstrated that sodium-glucose cotransporter-2 (SGLT2) inhibitors benefit heart failure patients, no matter how poor their ejection fraction is or whether or not they have diabetes. Find out how much empagliflozin reduced the risk of cardiovascular death and hospitalization in patients with severe heart failure.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -